The cost-effectiveness of blue-light therapy in the treatment of mild-to-moderate psoriasis

2017-06-01

Additional Metadata
Keywords	blue-light therapy, calcipotriol and betamethasone dipropionate gel, cost-effectiveness, Dovobet®, mild-to-moderate psoriasis
Persistent URL	doi.org/10.2217/cer-2017-0007, hdl.handle.net/1765/101095
Journal	Journal of Comparative Effectiveness Research
Note	no subscription
Organisation	Institute for Medical Technology Assessment (iMTA)
Citation APA Style AAA Style APA Style Cell Style Chicago Style Harvard Style IEEE Style MLA Style Nature Style Vancouver Style American-Institute-of-Physics Style Council-of-Science-Editors Style BibTex Format Endnote Format RIS Format CSL Format DOIs only Format	Ansaripour, A., Thio, B., Maessen, R. (Rob), & Redekop, K. (2017). The cost-effectiveness of blue-light therapy in the treatment of mild-to-moderate psoriasis. Journal of Comparative Effectiveness Research, 6(4), 325–335. doi:10.2217/cer-2017-0007

Publication